Showing results (211-220 of 275) with videos related to
Sort By:
Pageof 28
Annals of Hematology|January 3, 2025
Long-term clinical outcome of a weekly 2-chlorodeoxyadenosine regimen in treatment-naïve patients with hairy cell leukemiaYe Eun Oh, Gi-June Min, Young-Woo Jeon, et al.Annals of Hematology|September 7, 2011
Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantationByung-Sik Cho, Ji-Young Lim, Seung-Ah Yahng, et al.Journal for Immunotherapy of Cancer|February 9, 2019
Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantationSung-Eun Lee, Ji-Young Lim, Tae Woo Kim, et al.Immune Network|September 2, 2017
Distinct Clinical Outcomes between Paramedullary and Extramedullary Lesions in Newly Diagnosed Multiple MyelomaKhishigjargal Batsukh, Sung-Eun Lee, Gi June Min, et al.British Journal of Haematology|November 26, 2013
Influence of ex vivo purging with CliniMACS CD34(+) selection on outcome after autologous stem cell transplantation in non-Hodgkin lymphomaSeung-Ah Yahng, Jae-Ho Yoon, Seung-Hwan Shin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 14, 2018
Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic SyndromeSung-Soo Park, Young-Woo Jeon, Gi June Min, et al.European Journal of Haematology|February 19, 2013
Superior transplantation outcomes of 8/8-matched unrelated donors as well as matched siblings to autologous transplantation for acute myeloid leukemia with intermediate cytogenetics in first remissionByung-Sik Cho, Jung-Ho Kim, Jae-Ho Yoon, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 2, 2013
Serial measurement of WT1 expression and decrement ratio until hematopoietic cell transplantation as a marker of residual disease in patients with cytogenetically normal acute myelogenous leukemiaJae-Ho Yoon, Hee-Je Kim, Seung-Hwan Shin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantationByung-Sik Cho, Chang-Ki Min, Hee-Je Kim, et al.Blood Research|October 19, 2017
Comparison of the effects of early intensified induction chemotherapy and standard 3+7 chemotherapy in adult patients with acute myeloid leukemiaJae-Ho Yoon, Hee-Je Kim, Dae-Hun Kwak, et al.Pageof 28